Literature DB >> 25545383

Pituitary and brain dopamine D2 receptors regulate liver gene sexual dimorphism.

Maria Cecilia Ramirez1, Ana Maria Ornstein, Guillermina Maria Luque, Maria Ines Perez Millan, Isabel Garcia-Tornadu, Marcelo Rubinstein, Damasia Becu-Villalobos.   

Abstract

Liver sexual gene dimorphism, which depends mainly on specific patterns of GH secretion, may underlie differential susceptibility to some liver diseases. Because GH and prolactin secretion are regulated by dopaminergic pathways, we studied the participation of brain and lactotrope dopamine 2 receptors (D2Rs) on liver gene sexual dimorphism, to explore a link between the brain and liver gene expression. We used global D2R knockout mice (Drd2(-/-)) and conducted a functional dissection strategy based on cell-specific Drd2 inactivation in neurons (neuroDrd2KO) or pituitary lactotropes. Disruption of neuronal D2Rs (which impaired the GH axis) decreased most of male or female-predominant class I liver genes and increased female-predominant class II genes in males, consistent with the positive (class I) or negative (class II) regulation of these genes by GH. Notably, sexual dimorphism was lost for class I and II genes in neuroDrd2KO mice. Disruption of lactotrope D2Rs did not modify class I or II genes in either sex, because GH axis was preserved. But surprisingly, 1 class II gene (Prlr) and female-predominant class I genes were markedly up-regulated in lacDrd2KO females, pointing to direct or indirect effects of prolactin in the regulation of selected female-predominant liver genes. This suggestion was strengthened in the hyperprolactinemic Drd2(-/-) female mouse, in which increased expression of the same 4 liver genes was observed, despite a decreased GH axis. We hereby demonstrate endocrine-mediated D2R actions on sexual dimorphic liver gene expression, which may be relevant during chronic dopaminergic medications in psychiatric disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25545383      PMCID: PMC4330309          DOI: 10.1210/en.2014-1714

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  52 in total

1.  Sex difference in rate of ring A reduction of delta 4-3-keto-steroids in vitro by rat liver.

Authors:  F E YATES; A L HERBST; J URQUHART
Journal:  Endocrinology       Date:  1958-12       Impact factor: 4.736

2.  Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy.

Authors:  Timothy S Tracy; Raman Venkataramanan; Douglas D Glover; Steve N Caritis
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

Review 3.  The dopamine D2 receptor: new surprises from an old friend.

Authors:  Antonello Bonci; F Woodward Hopf
Journal:  Neuron       Date:  2005-08-04       Impact factor: 17.173

Review 4.  Dopamine receptors: from structure to function.

Authors:  C Missale; S R Nash; S W Robinson; M Jaber; M G Caron
Journal:  Physiol Rev       Date:  1998-01       Impact factor: 37.312

5.  Gender-specific alterations in gene expression and loss of liver sexual dimorphism in the long-lived Ames dwarf mice.

Authors:  Daniel Amador-Noguez; John Zimmerman; Susan Venable; Gretchen Darlington
Journal:  Biochem Biophys Res Commun       Date:  2005-07-15       Impact factor: 3.575

6.  Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations.

Authors:  M A Kelly; M Rubinstein; T J Phillips; C N Lessov; S Burkhart-Kasch; G Zhang; J R Bunzow; Y Fang; G A Gerhardt; D K Grandy; M J Low
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

7.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

Review 8.  Pharmacokinetics of antiretrovirals in pregnant women.

Authors:  Mark Mirochnick; Edmund Capparelli
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.

Authors:  Isabel García-Tornadú; Marcelo Rubinstein; Bruce D Gaylinn; David Hill; Edith Arany; Malcolm J Low; Graciela Díaz-Torga; Damasia Becu-Villalobos
Journal:  J Endocrinol       Date:  2006-09       Impact factor: 4.286

10.  Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice.

Authors:  M A Kelly; M Rubinstein; S L Asa; G Zhang; C Saez; J R Bunzow; R G Allen; R Hnasko; N Ben-Jonathan; D K Grandy; M J Low
Journal:  Neuron       Date:  1997-07       Impact factor: 17.173

View more
  3 in total

Review 1.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

2.  Transcriptome Analyses of Female Somatotropes and Lactotropes Reveal Novel Regulators of Cell Identity in the Pituitary.

Authors:  Michael T Peel; Yugong Ho; Stephen A Liebhaber
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

Review 3.  Regulation of Sexually Dimorphic Expression of Major Urinary Proteins.

Authors:  Dustin J Penn; Sarah M Zala; Kenneth C Luzynski
Journal:  Front Physiol       Date:  2022-03-31       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.